Share this article
Share this article
MORRISVILLE, N.C., May 11, 2021 /PRNewswire/ AAD, developer of rapid diagnostic and data systems, today announced a $7M investment to grow the company s platform for fast, point-of-care decisions in animal and human health, supporting One Health objectives to protect human, animal and environmental health. Funds will support commercial expansion of livestock tests and 510(k) submission to the U.S. Food & Drug Administration (FDA) for human blood tests. Mountain Group Partners (MGP) led the round, which included new investors Alexandria Venture Investments and Herbert Group Ltd. as well as Intersouth Partners, Murphy Family Ventures, Labcorp and others.
Seattle startup TwinStrand raises $50M to expand tech that identifies rare genetic mutants
May 5, 2021 at 10:55 am
Jesse Salk, CEO and co-founder of TwinStrand Biosciences. (TwinStrand Photo)
New funding: Gene-sequencing startup TwinStrand Biosciences raised $50 million in a Series B round led by Section 32, a California-based fund focused on biotech, technology, healthcare and life sciences. Total venture capital funding is now north of $70 million for the 6-year-old company.
Double strands of innovation: TwinStrand, which spun out of the University of Washington, has developed technology in both gene sequencing and analyzing sequencing results to help it find what the company calls “genetic needles in the haystack.”
Molecular Assemblies Closes Oversubscribed $24 Million Series A Financing to Advance Enzymatic DNA Synthesis toward Initial Commercial Access
News provided by
Share this article
Share this article
SAN DIEGO, April 15, 2021 /PRNewswire/ Molecular Assemblies, Inc., today announced that it has closed an oversubscribed $24 million Series A financing with significant investment from Agilent Technologies, iSelect Fund, Codexis, Alexandria Venture Investments, and Argonautic Ventures. In addition LYFE Capital has joined the syndicate. The proceeds of the financing will be used to advance the company s proprietary enzymatic DNA synthesis technology toward early commercialization efforts. We have made significant progress in advancing our proprietary enzymatic DNA synthesis technology, said Michael J. Kamdar, President and CEO of Molecular Assemblies. Over the past year, we ve entered into a transformative partnership with Codexis and joined a new project with GE Research to enabl
Molecular Assemblies Picks Up $24M For DNA Synthesis socaltech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from socaltech.com Daily Mail and Mail on Sunday newspapers.